Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Pharm Sin B ; 14(1): 20-37, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38239239
2.
Mol Neurobiol ; 61(7): 4834-4853, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38135855

ABSTRACT

With the aging of the population, treatment of conditions emerging in old age, such as neurodegenerative disorders, has become a major medical challenge. Of these, Alzheimer's disease, leading to cognitive dysfunction, is of particular interest. Neuronal loss plays an important role in the pathophysiology of this condition, and over the years, a great effort has been made to determine the role of various factors in this process. Unfortunately, until now, the exact pathomechanism of this condition remains unknown. However, the most popular theories associate AD with abnormalities in the Tau and ß-amyloid (Aß) proteins, which lead to their deposition and result in neuronal death. Neurons, like all cells, die in a variety of ways, among which pyroptosis, apoptosis, and necroptosis are associated with the activation of various caspases. It is worth mentioning that Tau and Aß proteins are considered to be one of the caspase activators, leading to cell death. Moreover, the protease activity of caspases influences both of the previously mentioned proteins, Tau and Aß, converting them into more toxic derivatives. Due to the variety of ways caspases impact the development of AD, drugs targeting caspases could potentially be useful in the treatment of this condition. Therefore, there is a constant need to search for novel caspase inhibitors and evaluate them in preclinical and clinical trials.


Subject(s)
Alzheimer Disease , Caspases , Alzheimer Disease/drug therapy , Alzheimer Disease/pathology , Alzheimer Disease/enzymology , Alzheimer Disease/metabolism , Humans , Caspases/metabolism , Animals , tau Proteins/metabolism , Amyloid beta-Peptides/metabolism , Enzyme Activation , Caspase Inhibitors/therapeutic use , Caspase Inhibitors/pharmacology
3.
Molecules ; 27(21)2022 Oct 28.
Article in English | MEDLINE | ID: mdl-36364148

ABSTRACT

Ergot is the spore form of the fungus Claviceps purpurea. Ergot alkaloids are indole compounds that are biosynthetically derived from L-tryptophan and represent the largest group of fungal nitrogen metabolites found in nature. The common part of ergot alkaloids is lysergic acid. This review shows the importance of lysergic acid as a representative of ergot alkaloids. The subject of ergot and its alkaloids is presented, with a particular focus on lysergic acid. All methods of total lysergic acid synthesis-through Woodward, Hendrickson, and Szantay intermediates and Heck coupling methods-are presented. The topic of biosynthesis is also discussed.


Subject(s)
Claviceps , Ergot Alkaloids , Lysergic Acid , Lysergic Acid/metabolism , Claviceps/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...